Clinical trials show Mounjaros potential for substantial weight loss, with participants losing up to 20% of their body weight in a year when combined with lifestyle changes like dietary adjustments and regular exercise
The faster onset with Retatrutide does come with some considerations
Pauls Hospital and Vancouver General Hospital
In contrast, GLP-1 receptor agonists have a more modest effect on HF hospitalization (approximately 11% risk reduction
Numerous endogenous agonists activate the GLP-1R, including several forms of GLP-1, oxyntomodulin and glucagon, and multiple exogenous peptide agonists are approved, or in clinical development, for the treatment of type 2 diabetes and/or obesity 1,2
Insist on transparency about sourcing and lab testing for any injectable you receive